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ance of Sorbistin A1. Pathology, light and EM examination.
There is no modification of the kidney structure after 50 and 100
mglkg/day SOR A1 for 8 days in Fisher 344 and Wistar rats. Enzy-
matic studies. Sorbistin induced no alteration either of alanine
amino-peptidase or of N-acetyl-f3-D-glucosaminidase activities
on renal cortical slices. A decrease of a-D-galactosidase activity
with 100 mg/kg/day of SOR A1 and an inhibition of sphingomye-
linase activity with both 50 and 100 mg/kg/day were demon-
strated. Subcellular studies. No modification of lysosomal struc-
tural latency was observed with doses ranging from 5 to 100
mL' of standard lysosomal suspension. Likewise, respiratory ac-
tivity of isolated mitochondria was not altered by doses of SOR
A1 of 100 to 800 g mL' in the incubation medium. We com-
pared these results with those previously obtained in our labora-
tory for ten other aminoglycosides, which were all nephrotoxic.
Our observations led us to conclude that SOR A1 has likely a
very low order of toxicity. This molecule had only three amino-
groups: it thus appears that aminoglycoside effects on subcellular





Scanning electron microscopy of the renal papilla in experimen-
tal analgesic nephropathy in the mouse. 1. M. Al-Ani and Julia
Fourman. Departments ofAnatomy and Mull idiscipline Labora-
tories, School of Medicine, University of Leeds, Leeds, Eng-
land. Analgesic nephropathy was induced in the mouse by ad-
ministration of aspirin in the drinking water, and the develop-
ment of changes in the form and surface of the papilla were
followed by scanning electron microscopy (SEM). The drinking
water of 21 young adult mice (each weighing 20 to 25 g) was
replaced by a saturated solution of aspirin made up freshly each
day. Three experimental mice and one control from the same
batch were killed 10, 15, 20, 25, 30, 35, and 40 weeks after the
start of treatment. The mice were anesthetized, and the kidneys
were fixed in situ with 3% buffered glutaraldehyde, removed, bi-
sected through the long axis, and after further fixation prepared
for SEM. The first detectable change in the form of the papillae
was a generalized swelling producing a thickened blunt appear-
ance, followed by shrinkage and longitudinal furrowing. Later,
there was necrosis, loss of the tip, and repair resulting in shorten-
ing and gross distortion. At 10 weeks, there were changes in the
surface epithelium, and a few cells at the tip appeared collapsed,
with a concave surface in place of the normal convexity. These
changes progressed in severity, and at 20 weeks crumpled cell
remnants formed ribbon-like bands surrounding islands of
healthy tissue. At 25 weeks, the openings of the ducts were dis-
torted by an overgrowth of large swollen cells. The papillary epi-
thelium receives its blood supply from vasa recta, and the pat-
tern of islands of healthy cells surrounded by dying cells is con-
sistent with reduced flow through the vasa recta, resulting in
ischemia of cells on the periphery of the area supplied. The col-
lecting duct epithelium probably receives some oxygen from the
urine, which would account for the hyperplasia of cells around
the openings. The denuded surface may be covered in the same
way after loss of the necrotic tip.
Sexual function in chronic renal failure: No benefit from zinc. A.
C. Brook, D. G. Johnston, M. J. Watson, D. B. Cook, M. K.
Ward, and D. N. S. Kerr. Welicome Research Laboratories,
Royal Victoria Infirmary, Newcastle upon Tyne, England. Sex-
ual function. In a cross-sectional study of 43 male patients with
chronic renal failure (9 treated conservatively, 22 dialyzed, 12
transplanted), sexual function was assessed by questionnaire.
Fifty percent of dialyzed patients and similar proportions of the
other groups considered their sexual potency to be decreased or
absent; 44% of all married men had not had intercourse in the
preceding week. Plasma testosterone was decreased in all three
groups: normal controls, 26.4 0.8 nmoles/liter (N = 17); non-
dialyzed, 16.9 2.5 nmoles/liter, P <0.001; dialyzed, 16.5 1.2
nmoles/Titer, P < 0.001; and transplanted patients 14.0 1.2
nmoles/liter, P < 0.001. Serum leutinizing hormone (LH) was
raised in all three groups, suggesting that the fundamental abnor-
mality was primary testicular failure. In 14 dialyzed patients, the
20-mm response to gonadotropin releasing hormone (GN-RH)
was exaggerated, confirming primary testicular failure. Plasma
testosterone correlated positively with potency assessed by
questionnaire (P < 0.001) in dialyzed subjects, suggesting
that inadequate androgenization was a cause of sexual dys-
function. Basal follicle-stimulating hormone (FSH) levels were
raised in the transplant recipients: normal laboratory range,
1 to 7 U/liter, transplanted patients, 10.7 U/liter (2.6 to >50),
P < 0.02. This suggested germ cell damage, probably re-
sulting from immunosuppressive therapy because FSH levels
were normal in most other patients. Simultaneous studies sug-
gested only a small role for autonomic dysfunction and psycho-
logic factors in sexual dysfunction. Zinc therapy. An important
role for zinc deficiency in the sexual dysfunction of dialyzed pa-
tients has been suggested by other authors. Serum zinc levels in
Newcastle patients were reduced: normal controls, 114.6 5.9
g/d1 (N = 13); nondialyzed, 83.7 3.7 g/dl, P < 0.01; dia-
lyzed, 86.3 5.2 zg/dl, P < 0.01; and transplanted patients, 84.6
4.5 ig/dl, P <0.01. Serum zinc correlated weakly with testicu-
lar volume (r = 0.551, P < 0.05), but not with any measure of
sexual function or endocrine status. A double-blind trial of zinc
repletion (N = 7) or placebo administration (N = 7) was per-
formed. Therapy was administered via the dialysis fluid for a 6-
week period. Nocturnal penile tumescence was measured by a
strain-gauge technique. This method has been shown to dif-
ferentiate between organic and psychogenic impotence; it con-
firmed that impotence in all our patients studied was organic.
Serum zinc levels were raised 16% by zinc administration. There
was no effect on questionnaire response, nocturnal erection,
plasma testosterone, LH, and FSH before and after Gn-RH. We
conclude that zinc deficiency is not of major importance in the
sexual dysfunction of dialyzed patients.
Studies on the significance of bacterial adherence in experimen-
tal urinary tract infection. S. Chick, M. J. Harber, R. Mackenzie,
A. W. Asscher, andD. B. Moffat. KR UF Institute of Renal Dis-
ease, Welsh National School of Medicine, Royal Infirmary, and
Department of Anatomy, University College, Cardiff, Wales.
Adherence of bacteria to mucosal surfaces is an important step in
their ability to produce infection. The present study was per-
formed to compare the ability of four strains of Escherichia coil
to adhere to bladder mucosa in vitro with their in vivo survival in
the rat urinary tract, and to investigate whether incubation in
2.5% u-mannose or alpha-methyl-D-mannoside (amm) will inter-
fere with this adherence. In vitro adherence was measured by
incubating strips of bladder mucosa in suspensions of bacteria,
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and viable counts were performed on the homogenated mucosal
strips. Persistence of bacteriuria was measured by taking urine
samples by suprapubic incision on days 1,3,5,7, and 10 follow-
ing introduction of bacteriuria. Results showed a significant cor-
relation between adherence of the four strains to bladder mucosa
compared with their persistence in the urinary tract. The adher-
ence of bacteria was reduced in the presence of D-mannose,
whereas bacteriuria was less persistent when the organisms were
suspended in 0-mannose and amm compared with isotonic sa-
line.
Do dialyzed patients need folic acid supplements? J. Cunning-
ham, V. L. Sharman, F. J. Goodwin, and F. P. Marsh. Depart-
ment of IVephrologv, The London Hospital, London, England.
To determine whether folic acid supplements should be given to
patients receiving regular hemodialysis, we measured the loss of
the vitamin during dialysis and studied the relationship of our
patients' hemoglobin concentrations (Hb) to their serum and red
cell folate concentrations. The loss of folate during dialysis was
estimated in 15 patients by measuring its concentration gradient
across the dialyzer. The median loss was 37.3 pg/dialysis, equiv-
alent to 16.0 pg/day, assuming thrice-weekly dialysis. This is
much greater than the urinary loss of folate in normal subjects (1
to 10 gIday) and might have led to folate deficiency if intake had
been borderline. In 72 patients established on home hemo-
dialysis, none of whom had received folate supplements, there
was no relationship, however, between their Hb and folate stat-
us. Although serum folate was below normal in 14 patients, mean
Hb in this subgroup did not differ from that of the remainder, and
in only one was red cell folate abnormally low. The results sug-
gest that routine supplements of folic acid are not required by
patients receiving hemodialysis.
Dimer albumin formation in the urine of patients with the neph-
rotic syndrome. J. Doman and J. Hardwicke. Department of Im-
munology, University of Birmingham Medical School, Birming-
ham, England. At a previous meeting of the Society, we de-
scribed S-S covalently bonded polymerization of urinary
albumin in patients with nephrotic syndrome responsive to Ste-
roids. Biopsy samples have shown this polymerization to be asso-
ciated with minimal change disease and some cases of mem-
branous glomerulopathy. Polymerization results from urine pres-
ervation by freezing, and is usually initiated by steroid therapy.
We present further work on the chemistry of polymer formation:
(I) In nephrotic patients, albumin monomer in an altered state is
present in both serum and urine. In rabbits, a similar alteration in
serum albumin can be induced in vivo by steroid treatment. (2)
Polymerization only occurs in the presence of a dialyzable urine
fraction, present only in dimer positive urine samples. This frac-
tion is eluted in the final fraction (salt peak) of Sephadex GlO,
and is not a peptide, amino acid, or fatty acid. (3) Polymerization
can be inhibited by both altered albumin excess and dialysate
fraction excess and occurs between a pH of 5 and 10. (4) The
kinetics of polymer formation at low temperatures differ marked-
ly from those of solvent-isolated serum albumin. Polymerization
is inhibited also by physiologic and higher ionic strengths, but
not by low ionic strength. (5) An ultrafiltrate of normal serum
inhibits polymerization.
Influence of hypertension on the course of experimental glomer-
ulonephritis in rats. B. M. Iversen and J. Ofstad. Medical De-
partment A, University of Bergen, Norway. It is generally ac-
cepted that hypertension is an ominous prognostic sign in gb-
merulonephritis. The pathogenetic role of hypertension in
glomerular disease is, however, not well known, We have there-
fore studied the effect of salt-DOCA hypertension (HT) on the
course of heterologous immune complex glomerulonephritis
(HIG) in rats. This glomerulonephritis is induced in rats after
they receive an intravenous transfer of antibodies to renal tubu-
lar epithelial antigens raised in rabbits. The morphologic features
are nearly identical to epimembranous glomerulonephritis in
man. Four groups of rats were investigated: (A) rats with HIG,
(B) rats with HIG and HT induced 15 days after the transfer of
antiserum. (C) rats injected with normal rabbit serum and HT in-
duced 15 days after the injection, (D) Control normal rats inject-
ed with rabbit antisera. The first animal in group B died after 91
days. The last measurement in the four groups before animals
began to die is shown in the Table.
Electron microscopic examination showed immune deposits in
the subepithelial region of the glomerular basement membrane
(GBM) in groups A and B. The GBM seemed to be thicker in
group B than in group A. Duration of life was 500 days in groups
A and D. In group B, it was 148 20 days; and in group C, 244
31 (P = 0.002). Hypertension superimposed upon this model of
experimental glomerulonephritis increased proteinuria, de-
pressed serum albumin and creatinine clearance, and shortened
life span.
Platelet-aggregating immune complexes in idiopathic glomerulo-
nephritis and lupus nephritis. N. Kasai, A. Parbiani, P. Shep-
herd, P. Verroust, V. Yewdall, and J. S. Cameron. Department
of Medicine, Guy's Hospital, London, England, and Service de
Nephrologie, Hopital Tenon, Paris, France. Platelet-aggregating
material (PAM) is known to be present in sera from patients with
active SLE, but no studies of PAM have been made in patients
with idiopathic glomerulonephritis. We examined a total of 127
patients with various forms of glomerulonephritis identified by
renal biopsy, using the microtitre platelet-aggregating test of
Penttinen and Mylylla (1977), in comparison with both Clq bind-
ing and Raji cell asays. The platelet-aggregating test is not depen-
dent on complement binding by complexes and could detect 5
g/ml aggregated human IgG in normal serum; 95% of normal
subjects showed platelet-aggregating titres of 1/2 or 0. The PAM
detected in patients with SLE eluted from Sepharose CL6B col-
umns with an apparent mob wt of 600,000 to 900,000 daltons, thus
distinguishing it from monocbonal antiplatelet antibody, throm-
bin, and low molecular weight platelet-aggregating factor (usual-
ly called PAF). As expected, forms of nephritis such as SLE,
polyarteritis, acute postinfectious nephritis, and mesangiocapil-
lary glomerubonephritis (in which the other tests for immune
complexes are usually positive) showed high titres of PAM.
However, in addition sera from patients with both membranous
nephropathy and Henoch-SchOnlein purpura nephritis (which
are usually negative in other tests) were positive to a similar de-
gree. Although some patients with focal segmental sclerosis were
also positive, most patients with "minimal change" lesions



















A 6 305 3 152 3 43.8 3 58.9 3.7 37.6 3.2 3.05 0.2
B 9 271 15 226 9 257.2 73 54.0 3.0 24.5 3.3 1.70 0.1
C 6 306 10 210 7 59.0 10 58.5 3.8 33.6 1.9 2.45 0.2
D 6 326 11 141 4 17.1 1 63.4 2.1 39.6 1.5 3.25 0.3
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nephritis for up to 2'12 years, in parallel with Raji and Clq binding
assays, showed differing patterns of immune complex reactivity
between patients and after treatment in individual patients.
These serial studies are still in progress.
Intrarenal pressure and sodium excretion in chronic glomerulo-
nephritis. V. Willassen and J. Ofstad. Medical Department A,
University of Bergen, Norway. During the development of
chronic renal failure, sodium balance is maintained by an in-
creased fractional excretion of filtered sodium (FENa). Several
theories have been advanced to explain this functional adapta-
tion, and changes in peritubular physical factors have been pro-
posed as possible mediators. We have examined renal sodium
excretion in relation to intrarenal hydrostatic pressure, as ex-
pressed by the intrarenal venous pressure (IRVP; wedged pres-
sure), in four groups of patients with chronic glomerulonephritis
(group I: normal GFR, normotension, N = 9; group II: slightly
reduced GFR, hypertension, N = 9; group III: reduced GFR,
normotension, N = 7; group IV: reduced GFR, hypertension, N
7); and in 20 normal individuals (group V). Measurements
were made during hydropenia (C) and sustained volume expan-
sion (E) with isotonic saline increasing body weight by 3%.
In groups I and II, the renal handling of sodium did npt differ
significantly from normal. Mean IRVP was subnormal in these
groups, but the difference did not reach statistical significance (P
> 0.05). The increased FEND in groups III and IV was associated
with significantly decreased IRVP (P < 0.001), probably in-
dicating a subnormal peritubular capillary hydrostatic pressure
in these patients. This finding therefore suggests that increased
peritubular capillary hydrostatic pressure is not a mediator of the
increased FENa in chronic renal failure. If the reduction in peri
tubular capillary pressure is causally related to the increased









C EC B C E
I 9 139 5 150 7 0.7 0.1 2.0 0.2k 22.9 1.7 23.3 1.7
II 9 107 7 117 8b 0.9 0.2 5.9 2A 20.4 2.4 24.1 3•2b
III 7 38 5 40 4 2.5 0.6 7.7 l.5 13.9 l.3a 15.4 1.8
IV 7 32 l0 38 10b 3.6 1.5a 13.5 3•55 13.5 2.6a 16.3 3.l
V 20 128 3 134 5 0.9 0.1 2.8 03b 24.8 0.8 25.1 0.9
Values are means SEM.
a C-value significantly different from normal (group V) (P < 0.05)
b Significantly different from C-value in same group (P < 0.05)
